logo-large
  • Browse Categories

Publications by authors named "Joshua Hessler"

Claim this Profile
U
Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.
Yuh-Ying Yeh, Rong Chen, Joshua Hessler, Emilia Mahoney, Amy M Lehman

Oncotarget· February 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic versus reactive PEG tube placement in head and neck cancer.
Scott Kramer, Matthew Newcomb, Joshua Hessler, Farzan Siddiqui

Otolaryngol Head Neck Surg· March 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, Jennifer A Woyach, Samantha Jaglowski, Joshua D Hessler

Blood· October 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells.
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, Joshua D Hessler, Xiaoli Zhang

Blood· October 2010


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: